Enovis Corporation (CFX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Enovis Corporation (CFX:NYSE), powered by AI.

Current Price
$21.80
Sector
Unknown
What is the Enovis Corporation stock price forecast?

Enovis Corporation is currently trading at $21.80. View real-time AI analysis on Alpha Lenz.

What is Enovis Corporation insider trading activity?

View the latest insider trading data for Enovis Corporation on Alpha Lenz.

What is Enovis Corporation's P/E ratio?

View Enovis Corporation's valuation metrics on Alpha Lenz.

Enovis Corporation

NYSE · CFX
$21.80+0.68(+3.22%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Enovis Corporation's future dividend policy...
Alpha Chat Insight

Enovis Corporation's ROE is 286.6%. Explore profitability and growth together.

Ask for details

Company Overview

Enovis Corporation is a medical technology company focused on developing and manufacturing innovative orthopedic care and rehabilitation solutions. The company operates primarily through two business segments: Prevention & Recovery, which encompasses bracing, supports, and other therapies designed to prevent injury and enhance patient recovery, and Reconstructive, which provides products for joint replacement and surgical interventions aimed at restoring patient mobility. Enovis has evolved from its origins as Colfax Corporation, previously a diversified industrial manufacturing firm, to a dedicated medtech enterprise following significant acquisitions and strategic divestitures, most notably the purchase of DJO for orthopedic platforms and the spinoff of its fabrication technology segment as ESAB Corporation. Leveraging a heritage of operational excellence and continuous improvement—principles rooted in the company’s founding by the Rales brothers—Enovis is committed to driving better clinical outcomes and transforming workflows in healthcare settings. It serves hospitals, clinics, and healthcare providers worldwide, contributing to advancements in patient care through innovations that improve mobility and quality of life. Today, Enovis is recognized for its strong focus on growth, industry leadership in orthopedics, and its vital role in the broader health technology sector.

SectorUnknown
IndustryUnknown
0

Company Statistics

FY 2021

Profile

N/AMarket Cap
$3.85BRevenue
0.00Shares Out
0Employees

Margins

41.87%Gross
14.49%EBITDA
7.38%Operating
4.29%Pre-Tax
1.98%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

1.68%Rev 3Yr
N/ARev 5Yr
-3.32%Op Inc 3Yr
N/AOp Inc 5Yr
-20.96%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

2.94%ROA
286.61%ROE
8.19%ROIC

Financial Health

$719.37MCash & Cash Equivalents
$2.70BNet Debt
4669.71%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Enovis Corporation (ticker: CFX) is a company listed on NYSE in the Unknown sector (Unknown).

The current price is $21.8 with a P/E ratio of -x and P/B of -x.

ROE is 286.61% and operating margin is 7.38%. Annual revenue is $3.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Enovis Corporation (CFX) Stock Forecast 2026 $21.80 — Price, Financials & Analyst Targets | Alpha Lenz